Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gene sequence fragment patents allowed under EU biotech patent directive.

Executive Summary

EUROPEAN BIOTECH PATENT DIRECTIVE WOULD ALLOW GENE FRAGMENT PATENTS if a genetic sequence fragment meets the general requirements of novelty, level of invention and industrial application. "An industrial application must be disclosed in the patent application," the directive instructs. "A mere sequence of DNA segments does not contain a technical teaching and is therefore not a patentable invention." The first reading of the "Directive on the Legal Protection of Biotechnological Inventions" was passed in the European Parliament July 16 by a vote of 388-110.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030571

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel